Cell Separation Technologies Market Report 2026

The cell separation technologies market size has grown rapidly in recent years. It will grow from $11.5 billion in 2025 to $13.11 billion in 2026 at a compound annual growth rate (CAGR) of 14%. The growth in the historic period can be attributed to growth in stem cell research activities, increasing use of cell-based assays, expansion of academic and biomedical research institutes, rising adoption of flow cytometry techniques, availability of advanced separation consumables.

The cell separation technologies market size is expected to see rapid growth in the next few years. It will grow to $22.2 billion in 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing demand for personalized medicine research, rising investments in cell-based therapeutics, expansion of automated laboratory workflows, growing focus on reproducibility in cell analysis, increasing integration of ai-assisted cell sorting tools. Major trends in the forecast period include increasing adoption of high-purity cell isolation techniques, rising use of magnetic and fluorescence-based sorting systems, growing demand for automated cell separation instruments, expansion of application-specific separation kits, enhanced focus on high-throughput cell processing.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the cell separation technology market. Chronic diseases are conditions that persist for a year or longer, often requiring ongoing medical care, limiting daily activities, or both. Common chronic conditions include cancer, cardiovascular diseases, stroke, diabetes, and arthritis. The rising burden of chronic diseases is attributed to changes in lifestyle behaviors, social and economic disparities, infections, genetic and autoimmune factors, and mental health challenges. Cell separation technologies support advancements in chronic disease treatment by enabling the isolation of cancer cells, immune cells, and other disease-relevant cell types for research, diagnosis, and therapeutic development. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, around 194 million adults in the United States, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among middle-aged adults, and 93% among older adults. Therefore, the rising burden of chronic diseases is fueling the expansion of the cell separation technology market.

Major companies operating in the cell separation technologies market are concentrating on the development of innovative solutions, such as automated temperature-controlled tissue dissociation systems, to standardize and speed up the conversion of solid tissues into viable single-cell suspensions for downstream applications. Automated temperature-controlled tissue dissociation systems are devices that integrate controlled mechanical motion, precise temperature regulation, and optimized enzymatic digestion protocols to safely and consistently dissociate tissues into individual cells. For instance, in June 2025, STEMCELL Technologies, a Canada-based supplier of cell culture media, separation reagents, and instruments for cell biology research, introduced the STEMprep Tissue Dissociator System. Key features include precise temperature control from 4 °C to 37 °C to optimize enzymatic performance and maintain cell viability, fully automated workflows that minimize manual handling and improve reproducibility, a modular configuration supporting 4-, 8-, or 12-sample processing, and flexible protocols using validated STEMCELL enzymes or user-defined methods for various tissue types. This system enables researchers to save time, reduce variability, and preserve high primary cell viability, thereby enhancing the reliability of downstream single-cell analysis, flow cytometry, and cell therapy development.

In May 2024, Mirus Bio LLC, a US-based biotechnology company specializing in transfection reagents and gene delivery systems for genetic research and cellular applications, acquired Merck Group for $600 million. Through this acquisition, Mirus Bio LLC aims to strengthen its product portfolio and expand its capabilities in gene delivery technologies. Merck Group is a Germany-based science and technology company that produces pharmaceuticals, life science products, and specialty materials.

Major companies operating in the cell separation technologies market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, GE HealthCare Technologies, Corning Incorporated, Lonza Group, Sartorius AG, Bio-Rad Laboratories Inc., Pall Corporation, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Stemcell Technologies Inc., 10X Genomics Inc., Cytena GmbH, Pluriselect GmbH, Akadeum Life Sciences Inc., Cellenion, NanoCellect Biomedical Inc., Agilent Technologies Inc, Cytek Biosciences Inc, Cell Microsystems Inc, Nexcelom Bioscience, ChemoMetec.

North America was the largest region in the cell separation technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell separation technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell separation technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cell separation technologies market by increasing costs of imported flow cytometers, magnetic separators, laser systems, microbeads, antibodies, and specialty reagents used across research and clinical workflows. North America and Europe are most affected due to dependence on imported high-precision instruments, while Asia-Pacific faces pricing pressure on consumables and equipment exports. These tariffs are increasing procurement costs for laboratories and slowing instrument upgrade cycles. However, they are also encouraging regional manufacturing of consumables, localized assembly of instruments, and greater investment in domestic life sciences supply chains.

The cell separation technologies market research report is one of a series of new reports that provides cell separation technologies market statistics, including cell separation technologies industry global market size, regional shares, competitors with a cell separation technologies market share, detailed cell separation technologies market segments, market trends and opportunities, and any further data you may need to thrive in the cell separation technologies industry. This cell separation technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell separation technologies refer to the methods and tools used to isolate specific cell types from a heterogeneous cell mixture. These technologies play a critical role in biomedical research, clinical diagnostics, and therapeutic applications, with the goal of obtaining a purified population of target cells for further analysis or use.

The main products of cell separation technologies include instruments, consumables, and reagents. Instruments are the equipment utilized to support the isolation of specific cell populations from biological samples. The technologies employed include gradient centrifugation, surface marker-based separation, fluorescence-activated cell sorting, magnetic cell sorting, and filtration-based separation. These technologies are applied across areas such as stem cell research, immunology, neuroscience, cancer research, and others, and are offered to end users including biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, academic and research institutes, and others.

The cell separation technologies market consists of revenues earned by entities through cell sorting, pre-plating, cell isolation, and field flow fractionation (FFF). The market value includes the value of related goods sold by the service provider or included within the service offering. The cell separation technology market also includes sales of cell isolation kits and automated cell separation instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.